World News
– Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified. – Six Israeli...
Hi, what are you looking for?
– Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified. – Six Israeli...
– Mesupron, which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused pipeline...
RedHill Biopharma Ltd.(NASDAQ: RDHL; TASE: RDHL) , today announced preliminary positive data from a pre-clinical study with RHB-104 for the treatment of type 1...
– Weizmann Institute Research Shows that time is of the essence. – – New findings in mice suggest that merely changing...
– Illustration : sxc.hu/gmarcelo – A successful joint collaboration between researchers at the Hebrew University and startup company TyrNovo may lead to a potential...
– Can-Fite Eye Disease spin-off hopes to raise up to US$10 million on NYSE. Road show starts in July. – Can-Fite CEO Pnina Fishman...
– – /By Jewish Business News Correspondent / Kamada Ltd. (Nasdaq and TASE: KMDA) today announced that the Company was granted two key patents related...
– Teva will pay $40 million for the lung disease drug developer and up to $125 million in milestone payments plus royalties. – –...
– Nine of the date fruit varieties growing in Israel have been found to possess properties that protect against cardiovascular diseases. – – /...
– – / By Noncamels team / A tiny robot that swims around the circulatory system, detecting illnesses and treating them on the spot, sounds like...